Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways
- 作者Sara Previdi; Paola Maroni; Emanuela Matteucci; Massimo Broggini; Paola Bendinelli; Maria Alfonsina Desiderio
- 卷第46卷
- 期第9期
- 印刷ISSN0959-8049
- 文件大小3615.21KB
- 发表时间2010
- DOI10.1016/j.ejca.2010.02.036
Multikinase inhibitors in thyroid cancerL. Licitra; L. D. Locati · 2012
Multikinase Inhibitor Treatment in Thyroid CancerAncker, Ole Vincent; Krüger, Marcus; Wehland, Markus; Infanger, Manfred; Grimm, Daniela · International Journal of Molecular Sciences · 2019
Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibCapdevila, Jaume; Stjepanovic, Neda · Biologics: Targets and Therapy · 2014
Timing of multikinase inhibitor initiation in differentiated thyroid cancerBrose, Marcia S; Smit, Johannes; Lin, Chia-Chi; Pitoia, Fabian; Fellous, Marc; DeSanctis, Yoriko; Schlumberger, Martin; Tori, Masayuki; Sugitani, Iwao · Endocrine-Related Cancer · 2017
Quantified Immunohistochemistry Demonstrates Cellular Level Targets of an Oral Multikinase Inhibitor in Metastatic Thyroid CancerEvan R. Ransom; Jason M. Leibowitz; Cathy Ma; Kanchan Puttaswamy; Andrea Troxel; William Lee; Michael Feldman; Marcia S. Brose · 2010
The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancerJerkovich, Fernando; García Falcone, María Gabriela; Pitoia, Fabián · Endocrine · 2019
Anti-Tumor Activity and Safety of Multikinase Inhibitors in Advanced and/or Metastatic Thyroid Cancer: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsTsoli, Marina; Alexandraki, Krystallenia I.; Spei, Maria-Eleni; Kaltsas, Gregory A.; Daskalakis, Kosmas · Hormone and Metabolic Research · 2019